Bender Robert & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9M | Sell |
26,712
-313
| -1% | -$139K | 2.65% | 10 |
|
|
2025
Q1 | $13.1M | Sell |
27,025
-281
| -1% | -$136K | 3.31% | 8 |
|
|
2024
Q4 | $11M | Buy |
27,306
+172
| +0.6% | +$69.3K | 2.65% | 12 |
|
|
2024
Q3 | $12.6M | Buy |
+27,134
| New | +$12.6M | 2.68% | 11 |
|
|
2024
Q2 | – | Sell |
-28,172
| Closed | -$11.8M | – | 44 |
|
|
2024
Q1 | $11.8M | Sell |
28,172
-378
| -1% | -$158K | 2.76% | 13 |
|
|
2023
Q4 | $11.6M | Buy |
28,550
+96
| +0.3% | +$39.1K | 2.93% | 11 |
|
|
2023
Q3 | $9.89M | Buy |
28,454
+47
| +0.2% | +$16.3K | 2.89% | 12 |
|
|
2023
Q2 | $10M | Sell |
28,407
-430
| -1% | -$151K | 2.76% | 11 |
|
|
2023
Q1 | $9.09M | Sell |
28,837
-22
| -0.1% | -$6.93K | 2.81% | 12 |
|
|
2022
Q4 | $8.33M | Buy |
28,859
+5
| +0% | +$1.44K | 3.12% | 9 |
|
|
2022
Q3 | $8.35M | Buy |
28,854
+683
| +2% | +$198K | 3.24% | 10 |
|
|
2022
Q2 | $7.94M | Sell |
28,171
-271
| -1% | -$76.4K | 3.04% | 12 |
|
|
2022
Q1 | $7.42M | Sell |
28,442
-1,668
| -6% | -$435K | 2.11% | 14 |
|
|
2021
Q4 | $5.46M | Hold |
30,110
| – | – | 1.58% | 16 |
|
|
2021
Q3 | $5.46M | Sell |
30,110
-273
| -0.9% | -$49.5K | 1.56% | 16 |
|
|
2021
Q2 | $6.13M | Buy |
30,383
+238
| +0.8% | +$48K | 1.74% | 15 |
|
|
2021
Q1 | $6.48M | Buy |
+30,145
| New | +$6.48M | 2.08% | 14 |
|